CompletedPhase 2NCT00005962
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eastern Cooperative Oncology Group
- Principal Investigator
- Mark R. Litzow, MDMayo Clinic
- Intervention
- sargramostim(biological)
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2000 – 2007
Study locations (30)
- CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
- Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States
- Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
- Stanford University Medical Center, Stanford, California, United States
- CCOP - Colorado Cancer Research Program, Inc., Denver, Colorado, United States
- CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
- Veterans Affairs Medical Center - Gainsville, Gainesville, Florida, United States
- Veterans Affairs Medical Center - Miami, Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
- Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
- CCOP - Central Illinois, Decatur, Illinois, United States
- CCOP - Evanston, Evanston, Illinois, United States
- CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00005962 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.